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Background: Isolation of bone marrow cells, including hematopoietic stem cells, is a commonly used technique in
both the research and clinical settings. A quantitative and qualitative assessment of cell populations isolated from
mouse and human bone marrow was undertaken with a focus on the distribution of hematopoietic cells between
the central bone marrow (cBM) and endosteal bone marrow (eBM).
Methods: Two approaches to cBM isolation from the hind legs were compared using the C57BL/6J and BALB/cJ
strains of laboratory mice. The content of hematopoietic stem cells in eBM was compared to cBM from mice and
human fetal bone marrow using flow cytometry. Enzymatic digestion was used to isolate eBM and its effects on
antigen expression was evaluated using flow cytometry. Humanized immunodeficient mice were used to evaluate
the engraftment of human precursors in the cBM and eBM and the effects of in vivo maturation on the fetal stem
cell phenotype were determined.
Results: The two methods of mouse cBM isolation yielded similar numbers of cells from the femur, but the faster
single-cut method recovered more cells from the tibia. Isolation of eBM increased the yield of mouse and human
stem cells. Enzymatic digestion used to isolate eBM did, however, have a detrimental effect on detecting the
expression of the human HSC-antigens CD4, CD90 and CD93, whereas CD34, CD38, CD133 and HLA-DR
were unaffected. Human fetal HSCs were capable of engrafting the eBM of immunodeficient mice and their
pattern of CD13, CD33 and HLA-DR expression partially changed to an adult pattern of expression about
1 year after transplantation.
Conclusions: A simple, rapid and efficient method for the isolation of cBM from the femora and tibiae of
mice is detailed. Harvest of tibial cBM yielded about half as many cells as from the femora, representing
6.4 % and 13 %, respectively, of the total cBM of a mouse based on our analysis and a review of the
literature. HSC populations were enriched within the eBM and the yield of HSCs from the mouse and
human long bones was increased notably by harvest of eBM.
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Collection of bone marrow (BM) from mice is an inte-
gral part of a broad range of studies in the fields of
hematology and immunology. Murine BM is also a
source of other cell types such as mesenchymal stromal
cells (MSCs), endothelial cells, osteoblasts, and osteo-
clasts [1–4]. BM samples are most typically obtained
from femora and sometimes tibiae. The method of iso-
lating BM cells typically involves cleaning some degree
of soft-tissue from the bone and flushing cells out of the
marrow cavity using a syringe with a fine needle [1].
However, based on descriptions in the literature and our
own research team’s experiences, there are a number of
different approaches to the isolation of BM from mouse
limb bones. The main difference in approach is whether
investigators choose to flush marrow from the bones by
removal of one [5] or both epiphyses [1]. Additionally,
investigators differ on the degree of soft tissue removal
performed prior to flushing the bones. Extensive re-
moval of soft-tissue can be a time-consuming process
with an uncertain benefit on the yield of BM cells.
The harvest of BM from human bone samples ob-
tained after surgery from living donors or from cadavers
is an important source of tissue for research [6] and may
also have clinical use [7]. For instance, BM harvested
from the long bones of fetal specimens has been used as
a source of hematopoietic stem cells (HSCs) [8] and
MSCs [9, 10] for research. These cells have also been
proposed as a source of donor cells for clinical trans-
plantation [11–13].
The distribution of cell types within the BM is not
homogeneous and, consequently, different harvest tech-
niques may vary in their efficiency in isolating particular
cell lineages [14]. Studies of the stem cell niche have
shown different types of stem cells and progenitors to
reside in different parts of the long-bone marrow. Lord
and Hendry were among the first to show an increased
density of hematopoietic precursors with distance away
from the central axis of the bone – referred to as the
central bone marrow (cBM) [15]. Accordingly, higher
levels of precursor proliferation are found near the inner
wall of the bone, closer to the endosteum, the location
of the endosteal bone marrow (eBM) [16].
Recently, Grassinger et al. demonstrated that pheno-
typically defined HSCs were enriched within the eBM
of the mouse [17]. These authors estimated that about
a quarter of all CD48−CD150+CD117+SCA-1+ lineage
(Lin)-depleted HSCs reside in the endosteum. Likewise,
human HSCs are enriched in the trabecular bone found
at the ends of the long bones [18]. In chimeric mice,
created by the transplantation of human HSCs into
immunodeficient mice [19], human HSCs are preferen-
tially localized to the eBM in the metaphysis and epi-
physis [18]. Similar to the findings on human bones,transplanted human HSCs were enriched in the trabe-
culae of the metaphysis/epiphysis of the murine femur.
To note, harvest of eBM is technically more time-
consuming and costly than simply flushing or rinsing
BM from bones as it involves removal of soft tissue,
crushing of the bone and enzymatic digestion [20].
One objective in performing this study was to discern
the most reliable, simplest and fastest method for the
routine isolation of cBM. Two methods were compared:
in one method, cBM was flushed from an incision at one
end of the bone after only minimal removal of soft tissue
and, in a second method, cBM was harvested following
removal of the majority of soft tissue and flushing the
cBM from one end of the bone and out the other end.
These two procedures are referred to simply as the
single-cut and double-cut methods, respectively. Both
methods were tested on the femora and tibiae of mice
and the number of cells obtained and the time required
for harvest was compared. In addition, researchers with
varying degrees of experience with these procedures
were studied to gauge the difficulty in learning the two
techniques. Herein, we also quantified the enzymatic
harvest of eBM to compare the efficacy of recovering
HSCs by this method compared to simple flushing
methods used to collect cBM. We not only evaluated the
benefit of harvesting eBM for the collection of murine
HSCs, but also human HSCs isolated from fetal BM and
humanized immunodeficient mice. Lastly, we compared
the phenotypic profile of human HSCs isolated from the
cBM and eBM from both fetal BM and from trans-
planted fetal cells recovered from humanized mice.Methods
Mice
This study was conducted with approval of the Institu-
tional Animal Care and Use Committee at ISIS Ser-
vices LLC (San Carlos, CA). The C57BL/6J and BALB/
cJ strains were purchased from The Jackson Laborator-
ies (Bar Harbor, MN and Sacramento, CA). Breeder
pairs of immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/
SzJ (NSG) mice were also obtained from The Jackson
Laboratories and bred at our institute. Additionally,
NOD.Cg-Prkdcscid Il2rgtm1Sug Tg(Alb-Plau)11-4/ShiJic
(uPA-NOG) mice were bred at our institute by crossing
uPA transgene hemizygous X homozygous mice [21].
Male and female mice were obtained through tissue
sharing whenever possible and killed by orbital enu-
cleation and exsanguination or by CO2 asphyxiation
and cervical dislocation. All animals were adults (≥8 weeks
of age) at the time of sacrifice. Mice were maintained in
microisolator cages in a facility free of commonly tested
murine pathogens and received humane care according
to the criteria outlined by the National Research Council’s
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for the Care and Use of Laboratory Animals”.Human tissues
Human fetal long-bones and liver were collected from
San Francisco General Hospital with consent from the
mothers undergoing elective abortions and with ap-
proval of the University of California San Francisco’s
Committee on Human Research. The gestational age of
the tissues used was between 20–24 weeks old estimated
based on the foot length of the fetus. All specimens were
donated anonymously.Harvest of mouse cBM
The following supplies are required to harvest cBM
from mice: 70 % ethanol, phosphate-buffered saline
(PBS), 50 ml and 15 ml tubes, sterile gauze pads, a
10 ml syringe, needles, forceps, and scissors. Unless
otherwise stated, 27 gauge, 13 mm needles (Becton
Dickinson, Franklin Lakes, NJ) were used in this
study, but testing of different needle gauges indicate
23 gauge needles offer the best performance. A video
has been posted online (see Additional file 1) dem-
onstrating the single-cut method of isolating cBM,
which was made following this protocol: Fill a 10 mL syr-
inge with PBS using a 50 ml tube as a reservoir. At-
tach a 23 gauge, 19 mm needle (Becton Dickinson,
Franklin Lakes, NJ) and bend 90° using the plastic
cap (Fig. 1a). After sacrifice, spray the mouse with
70 % ethanol to wet the fur to prevent its dispersal
before removal of the skin. Make a small incision in
the skin above the abdomen of the mouse (Fig. 1b).
From this cut, pull the skin apart and gently remove
the legs, one at a time, from the skin (Fig. 1c). The
legs are removed in the following manner: Bend back
the leg dorsally as if to dislocate the joint from the
pelvis. While pulling the leg, use scissors to make
three cuts to detach the leg from the pelvis (Fig. 1d).
The first cut is roughly parallel to the femur towards
the pelvis (Fig. 2), thereby removing soft tissue from
the femur while severing some of the soft-tissue that
connects the femur to the hip. The second cut is
made while dislocating the femur to reveal the prox-
imal epiphysis of the femur. The third cut, similar to
the first, is made parallel to the femur, towards the
knee, to further reduce the soft-tissue around the
femur and detach the leg. To collect the cBM from
the femur, remove the proximal epiphysis with scis-
sors (Fig. 1e). To reduce the loss of BM, it is import-
ant to cut just below the ball joint (Fig. 2). The red
BM should be visible. Insert the needle into the open-
ing of the bone (Fig. 1f ). Flush the cBM cells into a
collection tube by injecting approximately 0.5-3 mLof PBS while holding the bone over the opening of
the tube. For the tibia, remove the bulk of the soft
tissue by holding the tibia using forceps and cutting
roughly parallel towards the knee (Fig. 2). Cut the
proximal epiphysis of the tibia by cutting just below
the knee joint (Fig. 1). The white ligaments covering
the knee provide a landmark and the cut should be
immediately below this connective tissue. Flush cells
from the tibia as for the femur (Fig. 1g-h).
The double-cut method differed from the single-cut
method in that the bone was first cleaned of the majority
of soft tissue to allow for visualization of the bones.
Complete soft-tissue removal, as is sometimes per-
formed when isolating cBM [1], was not done to allow
the duration of the two isolation methods to be more
reasonably compared. Then, both the distal and prox-
imal epiphyses were removed and marrow was flushed
from the distal out the proximal end of the bones.
For both the single-cut and double-cut methods, the
volume of PBS used to harvest the cBM was not fixed.
The mean volume used to flush femora was 2.2 ml and
2.0 ml using the single-cut and double-cut methods, re-
spectively (n = 56). For the tibiae, an average of 1.8 ml
and 1.6 ml were used with the single-cut and double-cut
methods, respectively.
The time required to harvest the cBM by the single-
cut and double-cut methods was recorded starting at
the time of the excision of the leg. Data were collected
starting on the left leg and the method of harvest used
was alternated between the left and right legs to ac-
count for the handedness of the investigators. This
approach was used to balance the number of cBM
cells recovered and the time required to perform the
two procedures. Although the procedure was timed,
the investigators were instructed to primarily focus on
an accurate collection of the most cells possible with
the speed of the procedure being of secondary concern.
Isolation of mouse eBM
Murine eBM was harvested in a manner similar to a pre-
viously described method [20]. Briefly, femurs were re-
moved of all soft tissue using scissors and forceps. Bones
were cut into smaller fragments and digested with 3 mg/
ml collagenase I (Sigma Aldrich, St. Louis, MO) and
4 mg/ml dispase II (Roche Diagnostics Corporation,
Indianapolis, IN) at 37 °C for 5 minutes. The eBM was
filtered through a 40 μm strainer and washed once by
centrifugation.
Isolation of fetal human cBM and eBM
Human cBM was isolated from either a femur or all
long bones as previously detailed [12]. Briefly, bones
were denuded of all soft tissue, including the fibrous
periosteum, using a scalpel and scissors. cBM was
Fig. 1 Stepwise overview of the single-cut method for mouse cBM isolation. Panels (a)-(h) demonstrate the key steps in the isolation of cBM.
Refer to the protocol text for an explanation of the individual steps
Mahajan et al. BMC Hematology  (2015) 15:9 Page 4 of 17flushed with a 19 gauge needle (Becton Dickinson)
inserted, often at multiple sites, into both ends of
the bone and flushed with PBS until the red-cell
content of the marrow was visibly depleted. PBS was
used to rinse the bones. Each bone, immersed in fresh
PBS, was then cut in half lengthways and the cBM scraped
from the bone with a scalpel blade and filtered through a
100 μm cell strainer (Greiner Bio-One, Germany). The
cBM was washed once by centrifugation.
The bone fragments that remained after flushing and
filtration of the cBM were enzymatically digested to
isolate eBM as described for the mouse bones. The eBMwas filtered and washed once by centrifugation before
flow cytometric analysis.
Construction of humanized mice
Male and female mice were transplanted with human
hematopoietic cells to establish hematopoietic chimeras.
Immunodeficient uPA-NOG mice [21] were transplanted
with fetal liver cells, prepared as described [22]. Cells were
transplanted by intra-splenic injection without prior
cytoablative irradiation [23]. Additionally, NSG mice were
transplanted intravenously with 2 × 106 midgestation
light-density cBM cells after 175 cGy X-ray irradiation.
Fig. 2 Stepwise schematic of cuts made in soft-tissue and bone for the
isolation of mouse cBM. The direction and numerical sequence of
soft-tissue cuts are shown using red arrows. The approximate
location of cuts made to remove the bone epiphyses are
shown with dashed blue lines
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Human BM cells were suspended in blocking buffer con-
sisting of PBS with 5 % mouse serum and 0.01 % NaN3
and, for samples containing mouse BM, the blocking
buffer was supplemented with 2 μg/ml rat anti-mouse
CD16/CD32 mAb (BioLegend, San Diego, CA). Samples
were stained with monoclonal antibodies and live
cells, identified using propidium iodide staining, ana-
lyzed on a flow cytometer as previously described
[24]. Data were analyzed using FlowJo software, ver-
sion 9.7 (Tree Star, Inc.; Ashland, OR).
The following fluorescein isothiocyanate (FITC)-
labelled, phycoerythrin (PE)-labelled, allophycocyanin
(APC), PE-cyanine 7 (PE-Cy7), APC-cyanine 7 (APC-
Cy7), pacific blue (PB) or Alexa Fluor 700 (AF700)
antibodies were purchased from BioLegend or an
otherwise stated vendor: mouse IgG1 FITC, mouse
IgG1 PE, mouse IgG1 APC, mouse IgG1 PE-Cy7,
mouse IgG1 APC-Cy7 and mouse IgG2a PE. The fol-
lowing monoclonal antibodies were used to stain hu-
man cells: CD45 FITC (clone HI30), CD45 APC-Cy7(clone HI30), FITC-labeled mature lineage cocktail
(clones UCHT1, HCD14, 3G8, HIB19, 2H7, HCD56),
CD133 APC (clone AC133; Miltenyi Biotec, Auburn,
CA), CD133 PE (clone AC133; Miltenyi Biotec),
CD34 PE-Cy7 (clone 581), CD4 PE (clone L200; BD
Pharmingen, San Diego CA), CD13 APC (clone WM15;
BD Pharmingen), CD33 (clone WM53), CD38 PE (clone
HIT2), CD90 PE (clone 5E10), CD93 PE (clone VIMD2),
CD147 (clone TRA-1-85; R&D Systems, Minneapolis,
MN), HLA-DR FITC (clone L243; Becton Dickinson)
and HLA-DR PE (clone L243). The following monoclonal
antibodies were used to stain mouse cells: CD3 (clo-
ne17A2), CD11b (clone M1/70), CD45R (clone RA3-
6B2), Gr-1 (clone RB6-8C5), TER-119 (clone TER-119),
CD45 (clone 30-F11), H-2Kd (clone SF1-1.1) all PB
labelled, CD48 PE-Cy7 (clone HM48-1), CD117 (c-kit)
FITC (clone 2B8), CD150 (SLAM) PE (clone TC15-
12 F12.2) and SCA-1 APC (clone D7).Cell counts
Live cell counts were performed using a Scepter Hand-
held Automated Cell Counter with 40 μm sensors (EMD
Millipore Corporation, Billerica, MA, USA). Particles
>3 μm were counted.
Data presentation and statistical analysis
Statistical analysis and charting was performed using
Aabel 3 and Aabel NG software (Gigawiz Ltd. Co.
OK, USA). The 2-tailed Wilcoxon Matched-Pairs test
was used to determine the significance of differences
between cell yields obtained by the single-cut and
double-cut methods. The Mann–Whitney U-test was
used to determine the significance of differences in
cell population frequencies between cBM and eBM.
Differences were considered significantly different at
P ≤ 0.05. Notched box and whisker plots are used to
display some of the data where the box represents the
distribution of the 25th through 75th percentile of the
data and the whiskers extend to the extreme data
points. Medians are represented by the notch in the
box.
Results
Comparison of the single-cut and double-cut methods of
mouse cBM isolation
Two methods of mouse cBM isolation were tested.
Investigators with differing levels of experience with
the procedures performed these experiments to deter-
mine which method was best for experienced and
novice investigators (Table 1). The two methods were
compared to determine which was the most reliable
and/or fastest. The median time using the single-cut
method was much faster (76 seconds, n = 56) than the
Table 1 Summary of investigator experience and cBM collection times




A ≥25 years Single-cut 18 62 120
B ≥25 years Double-cut 5 98 187
C ≥5 years Single-cut 5 68 170
D <1 year Novice 12 88 174
E <1 year Novice 10 121 149
F <1 year Novice 6 75 117
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of experience level of the investigator (Fig. 3a and
Table 1). Not surprisingly, investigators experienced
with the single-cut method were able to perform their
isolations most rapidly (Table 1). Moreover, the single-
cut method was the fastest method for isolating cBM
from both the femora and tibiae (Fig. 3b).
The median number of cells harvested by the single-
cut method was 2.21 × 107, compared to 1.91 × 107 ob-
tained by the double cut method (n = 56, Fig. 3c). The
15.7 % increased yield of cBM obtained by the single-cut
method was not significant (P = 0.057). When the cell
yields were analyzed separately for the two hind-leg
bones a modest 8.2 % higher number of femoral cells
were recovered using the single-cut method (Fig. 3d),
which was not significantly higher than the yield ob-
tained with the double-cut method. However, the 19.4 %
increased recovery of cells from the tibia using the
single-cut method was significant (P = 0.043). Thus, the
single-cut method is a favorable method for isolating
cBM from both the femur and the tibia.
Given that the murine tibia is a smaller bone than the
femur and extra effort is required to harvest cells from
it, we sought to determine the quantity of cBM that
could be harvested from the tibia. The results were very
similar for two strains of mice analyzed (Fig. 3e). For
both strains combined, the tibia yielded about 54 % the
number of cells obtained from the femur. Stated in an-
other way, about a third of the cBM available for harvest
from a hind leg is found in the tibia.
We evaluated the cell yields individually by investiga-
tor to gain insight into the effects of experience on per-
forming the two procedures. There was no significant
difference in cell yield between the combined results of
the 3 experienced investigators and 3 novice investiga-
tors (n = 28 harvests each group) for either of the two
isolation methods. Investigators A and C, both experi-
enced with the single-cut method, did recover a signi-
ficantly higher number of cells using this method
(Fig. 3f ), whereas investigator B, previously experienced
with the double-cut method, obtained an insignificantly
greater number of cells with their familiar procedure.
There was no significant difference in cell yieldamong the novice investigators comparing the two
isolation methods.Comparison of the yields of hematopoietic precursors
found in mouse cBM and eBM
We sought to quantify the number of cells and, more spe-
cifically, hematopoietic precursors that remained in the
bones after flushing out cBM using the single-cut method.
Isolation of eBM recovered 84 % more cells than by flush-
ing alone. The yields of different hematopoietic progenitor
compartments were determined using flow cytometric ana-
lysis (Fig. 4a). The frequency (Fig. 4b) and total number
(Fig. 4c) of Lin− cells recovered from the femurs of 5 mice
were greater from the eBM than the cBM. Recoveries of
Lin−SCA-1+CD117+ (LSK) cells, Lin−CD48−CD150+ cells
and CD48−CD150+ LSK cells did not differ significantly be-
tween the cBM and eBM. These data indicate that approxi-
mately equivalent numbers of progenitors and HSCs can be
recovered from the cBM and eBM if flushed with a small
27 gauge needle size.
As the size of needle used to flush cBM from the long
bones may affect the recovery of cBM and eBM. We
compared harvests of cBM, from the femur and tibia,
using four needle sizes (Fig. 4d). There were no signifi-
cant differences in the yield of cBM using the different
gauged needles. There was, however, a more varied and
decreased median recovery using the largest needles (21
gauge). These needles were too large to easily insert in
the marrow cavities of tibiae resulting, sometimes, in
fractures. Indeed, there was a significant decrease in the
harvest of tibial cBM using 21 gauge needles compared
to 25 and 27 gauge needles (P = 0.016 and 0.007, respect-
ively), which affected the overall yield of cBM. The recov-
ery of the remaining eBM was less using 23 gauge needles
than using the smaller 27 gauge needles (Fig. 4e, P = 0.025),
which was mirrored by an increased recovery of femoral
cBM (not shown, P = 0.037). Using 23 gauge needles, the
recovery of eBM was only 1.1 % of cBM. Thus, increasing
the needle size up to 23 gauge can modestly increase the
recovery of cBM and reduce the amount BM cells left in
the femur. This affect wasn’t apparent using the even larger
21 gauge needles likely because the tight fit of these needles
Fig. 3 Comparisons of mouse cBM isolations using the single-cut and double-cut methods. The time required to isolate cBM by the two methods
is shown for both the femur and tibia (a) and for each of the long bones individually (b). The number of cells isolated by the two methods from
both long-bones is shown in (c) and cell yields for the individual bones are shown in (d). The percentages of tibial and femoral BM cells recovered from
BALB/cJ (n = 19) and C57BL/6J (n = 37) mice are shown (e). The median number of cells recovered from each bone using the single-cut method are
indicated in the legends. Cell yields are shown by investigator in (f). Refer to Table 1 for the number of harvests performed and the level of experience of
the investigator
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bones.
Comparison of hematopoietic precursors yields from fetal
human cBM and eBM
The eBM compartment was also examined in human
midgestation long bones. Four specimens of fetal human
long-bones were used to isolate cBM and eBM and therecovered cells were analyzed by flow cytometry to de-
termine the yield of HSCs as well as other BM cell pop-
ulations. In 3 of 4 experiments, eBM cells represented a
consistent 7 % of all BM cells recovered (Fig. 5). How-
ever, in one experiment, 57 % of cells were recovered
from the eBM fraction. We attribute this outlier to the
older age of the specimen and the fact that all the long
bones found in the legs and arms were processed instead
Fig. 4 (See legend on next page.)
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Fig. 4 The quantities of C57BL/6J mouse hematopoietic precursors from cBM and eBM. Flow cytometric analysis of cBM and eBM was used to
identify precursor populations using the gates indicated (a). Total cells were defined as live cells – lacking PI staining – from which doublets were
excluded by electronic gating (not shown). The median frequencies (b) and numbers (c) of cells recovered of each precursor population are
shown (n = 5). Note, that these data are shown on a logarithmic scale. The effects of needle size on the recovery of cBM (d) and eBM (e) cells are
shown for 6 samples for each group
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greater amount of tissue processed and hardness of the
bones most likely led to less efficient flushing of the
cBM, thereby resulting in a greater yield in the subse-
quent enzymatic digestion of the tissue.
To estimate the distribution of HSCs between the
cBM and eBM compartments of the fetal long bones,
two cell populations enriched in HSCs were enumerated
from the BM preparations: CD34++CD133+ and CD34++
CD38low cells (Fig. 5). In all four samples, the frequen-
cies of these primitive progenitors were enriched among
eBM cells. CD34++CD38low cells represent a small subset
of CD34++CD133+ cells and their yield was noticeably
lower than for CD34++CD133+ cells. A phenotypic pro-
file using a number of markers associated with HSCs
further demonstrates the enrichment of HSCs and
primitive progenitors among the eBM fraction of BM
cells (Fig. 6). The representative analysis shows the en-
richment of CD34++CD133+ and CD34++CD38low cells
found in the eBM fraction. Likewise, CD34++CD90+
cells, representing another population enriched in stem
cells [25], was also enriched more than 2-fold among
eBM cells. In fetal tissues, most primitive progenitors
express HLA-DR, although some are HLA-DRlow/-
[26, 27], whereas adult cells with the properties of HSCs
are enriched among HLA-DR− cells [28–30]. CD34++
HLA-DR+ cells were enriched among eBM cells, whereas
the frequency of CD34++HLA-DR− cells was more or
less similar in the two BM preparations. Overall, an
enrichment of primitive progenitor populations was
observed among eBM cells.
Two cell-surface markers associated with hema-
topoietic stem cells, CD4 and CD93, were notably absent
among eBM cells in contrast to the other markers that
were studied (Fig. 6). Since all the gated populations
shown in Fig. 6 are largely overlapping populations of
primitive hematopoietic cells, the lack of CD4 and CD93
expression was difficult to explain in light of the expres-
sion patterns of the other HSC markers. We therefore
tested if these antigens were susceptible to enzymatic re-
moval by digestion of cBM under the conditions used to
isolate the eBM cells. The panel of Lin markers, used to
mark mature cell populations, was modestly affected by
enzymatic digestions, whereas CD34 expression was not
diminished (Fig. 7). Among the markers used to define
hematopoietic stem cells and primitive progenitors, CD4
and CD93 were notably eliminated and CD90 waspartially reduced. The other markers were not appre-
ciably affected. Note that the loss of Lin antigen, result-
ing from enzymatic digestion, did reduce the frequency
of gated progenitor populations owing to the greater di-
lution of these populations by cells that would otherwise
be Lin+ cells.
Human precursors in the cBM and eBM cells of
humanized mice
Humanized mice provide a model for studying human
hematopoiesis in an in vivo setting [31]. We evaluated
cBM and eBM engraftment by human hematopoietic
precursors in uPA-NOG mice. In the first experiment,
mice were transplanted with hematopoietic precursors
isolated from fetal liver, which is the source of HSCs that
seed the BM during development. The first cohort of 5
mice were transplanted without irradiation to avoid the
cytoablative treatment that may damage the BM and
affect the seeding of the cBM and eBM. Although en-
graftment varied widely, as is typical of humanized mice,
precursors expressing CD34 and CD133 were observed
among both the cBM and eBM (Fig. 8a). The frequencies
of human hematopoietic precursors are shown among
all cBM and eBM cells as well as among only the
fraction of human CD45+ leukocytes found in the cBM
and eBM (Fig. 8b). The median percentage of CD34+/++
and CD133+CD34++ cells were modestly higher in the
eBM, but the increase was not significant given the
range of data from different chimeric mice.
Findings with the unirradiated uPA-NOG mice were
followed by transplanting NSG mice, after cytoablative
irradiation, with human 24 weeks’ gestation cBM cells.
Engraftment of both the cBM and eBM by CD133+
CD34++ cells was observed in two mice analyzed
356 days after transplant (Fig. 8c).
The phenotype of fetal HSCs differs somewhat from
that of adult HSCs. We hypothesized that long-term en-
graftment of human fetal cells in the adult environment
of immunodeficient mice would result in a switch from
a fetal to an adult phenotype. Most fetal HSCs express
HLA-DR, CD13 and CD33 in contrast to their adult
counterparts [26, 27]. We examined the expression of
these antigens after long-term engraftment in mice to
determine if the expression of these markers was lost
as on adult cells. HLA-DR, CD13 and CD33 were
expressed on cBM and eBM cells (Fig. 8c). In Fig. 8d,
expression was also compared on enriched HSCs
Fig. 5 Isolation of human hematopoietic precursors from cBM and eBM. The relative recovery of total cells (a), CD34++CD133+ cells (b) and
CD34++CD38low cells (c) from cBM and eBM are shown graphically for 4 samples. The number of cells recovered are indicated in the legends
above each triangle
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Fig. 6 Flow cytometric analysis of fetal human cBM and eBM. Side-by-side comparisons of cell surface markers on CD34++ cells. The frequencies
of gated cell populations among live-single cells are indicated in each plot. In addition to the markers shown, hematopoietic precursors were also
defined by their expression of CD45 and light-scatter gate that excluded high side-light scatter events (not shown). Femoral cells were obtained
from a 22 weeks’ gestation fetus
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ted-progenitors (CD133−CD34++). HLA-DR was strongly
expressed on cells expressing CD133, but had declined
on CD133−CD34++ cells. The most notable difference
found on CD34++ precursors from cBM and eBM was
a shift towards higher HLA-DR expression on CD133−
from the eBM compared to the cBM. CD13 expression
was not detected on any CD34++ precursors, whereas
a very low level of CD33 expression was observed on
CD133+ cells but not CD133− cells. These data indi-
cate that the fetal HSC phenotype has only partially
converted to an adult phenotype after nearly 1 year
in vivo.
Discussion
Mice are among the most commonly used laboratory an-
imals in research and the collection of BM from these
animals has become a matter of routine. However, some-
what surprisingly, protocols used for the isolation of BM
can vary notably from the very simple single-cut methodused in this study to the more cumbersome double-cut
methods employing varying degrees of soft-tissue re-
moval. This study was performed, in part, to determine
if these two methods are comparable in their yield of
cBM cells, which they were for harvesting femoral cBM.
In the case of the tibia, the single-cut method was found
to be superior for maximizing the number of cells that
can be harvested. The single-cut method was also not-
ably faster due to its simplicity. Also important, the
single-cut method was no more difficult to learn for
novice investigators than the double-cut method despite
the fact that the latter procedure provides greater
visualization of the bone prior to marrow harvest.
A complete harvest of BM is often a requirement for
many experiments, either to yield as many cells as pos-
sible for analysis or to perform a quantitative analysis of
the BM compartment. The higher efficiency of the
single-cut method makes it the preferable method to
harvest the maximum number of cBM cells. However,
the distribution of cell types within the BM is not
Fig. 7 (See legend on next page.)
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Fig. 7 Loss of some cell-surface markers on hematopoietic precursors owing to enzymatic digestion. Flow cytometric analysis was performed on
cBM before and after enzymatic digestion was performed as for the isolation of eBM. The data shown in the dot plots are gated on live, single,
low side-light scatter cells (not shown) as well as Lin− cells gated as indicated. Expression of CD133 is indicated using blue dots in all
dot plots. Numbers represent the frequencies of Lin− cells represented by the gated populations. Overlay histogram plots show the effects of enzyme
digestion on antigen expression. The expression of Lin antigens and CD34 are shown on live, single cells (gating not shown), whereas expression of the
remaining antigens are shown on live, single cells expressing CD34 as indicated. BM cells were obtained from a 20 weeks’ gestation fetus
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niques may vary in their efficiency in isolating particular
cell lineages [14]. Our own experience with the single-
cut method shows this method to effectively isolate
hematopoietic progenitors and long-term reconstituting
HSCs [32, 33]. Nonetheless, studies of the HSC niche
have shown different types of HSCs and progenitors to
reside in different parts of the long-BM. Lord and
Hendry showed an increased density of hematopoietic
precursors with distance away from the central axis of
the bone [15]. Accordingly, higher levels of precursor pro-
liferation are found near the inner wall of the bone, closer
to the endosteum [16]. More recently, Haylock et al.
and Grassinger et al. demonstrated that phenotypically-
defined HSCs were enriched within the eBM and that
the HSCs from eBM have greater proliferative and en-
graftment potential when compared to those from
cBM [17, 20]. These authors estimated that about a
third of LSK cells and a quarter of CD48−CD150+
LSK cells reside in the endosteum. Our results yielded
somewhat higher recoveries of 49 % of LSK cells and
39 % of CD48−CD150+ LSK cells from the eBM. The
higher yields are likely due to subtle differences in
methods, techniques and the bones used to isolate
cBM and eBM. On of these differences could be the
size of the needle used to isolate the cBM. We found
23–27 gauge needles to be similarly effective in har-
vesting cBM, but would recommend 23 gauge needles
to maximize the recovery of cBM and minimize the
quantity of eBM remaining in the marrow. Nonethe-
less, a complete harvest of HSCs requires harvest of
the eBM.
Our study also reveals the value of harvesting tibial
BM to increase the overall recovery of BM cells. Data on
two common strains of mice show that the tibia can
provide an additional 54 % of the number of cells col-
lected from the femur alone. Thus, harvesting the tibia
is a good option for increasing the yield of BM cells with
minimal extra time required for the collection. The
quantity of BM in different long bones has been mea-
sured by a number of investigators using mice pulsed
with 59Fe to radioactively label developing erythroid cells
(Table 2). An average femoral BM content from six stud-
ies is 6.5 % of total skeletal BM [5, 34–38]. We found
only one reported value for tibial BM measured at 3.5 %
[34]. However, three other studies measured BM content ofboth the tibia and fibula at an average 3.1 % [5, 36, 38].
Since the tibia contains nearly all the BM of these two
bones, we consider it reasonable to average the tibial meas-
urement made by Chervenick et al. with the other three re-
ported measurements; the average estimate from four
studies for tibial BM content is 3.2 %. Based on our calcu-
lated averages, harvest of a single femur and tibia should
yield 9.7 % of the total skeletal BM (19.4 % for both hind
limbs). This estimate is in close agreement with total hind
limb measurements made by Boggs and Patrene ranging
from 8.4 to 10.75 % [39]. These combined BM measure-
ments are also in agreement with our measurement of an
approximate 2:1 ratio of cell content in the femur and tibia.
We evaluated the benefit of enzymatic digestion to iso-
late fetal human eBM cells. Although the method used
for enzymatic digestion of the human BM was that same
as for the murine samples, it is important to note that
the isolation of human cBM by flushing was prone to
more variability. Unlike the single-cut method where in-
sertion of the needle into the BM cavity leaves little
room for variability, flushing of the larger human bones
requires multiple needle-point entries and physical
crushing of the bones to access the cBM throughout the
marrow cavity. A simple visual goal employed in cBM
isolation was to flush most of the red cells from the
bones. Nonetheless, the amount of tissue processed, the
size of the bone and the gestational age of the sample
can all affect the harvest. We observed eBM to comprise
a consistent minimum of 7 % of the total BM content.
We observed an increased frequency of phenotypically
defined HSCs in the eBM preparations made from fetal
long bones. These results are in agreement with the re-
ported enrichment of HSCs in the trabecular bone area
of adult posterior ileac crest by Guezguez et al. [18].
These authors observed a higher frequency of Lin−CD34
++CD38−CD45RA−CD49f+ cells in the trabecular bone
area, found near the surface of the bone biopsy, com-
pared to the long bone area, defined as being closer to
the central core of the biopsy. We observed HSC subsets
such as CD34++CD133+, CD34++CD38low, CD34++CD90+
and CD34++HLA-DR+ cells enriched among eBM cells.
It was also noted that the enzymatic digestion used to
isolate the eBM cells reduced CD4, CD90 and CD93
antigen expression and, consequently, HSCs are best
identified using antigens less prone to enzymatic diges-
tion such as CD133, CD38 and HLA-DR.
Fig. 8 (See legend on next page.)
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Fig. 8 Engraftment of the cBM and eBM by human cells in immunodeficient mice. uPA-NOG mice analyzed 308 days after transplant showed
engraftment by CD34+/++ (large rectangular region) and CD133+CD34++ (smaller gated subset) cells in both the cBM and eBM (a). The
frequencies of these precursor populations found among all live, single cells and human CD45+ cells are shown using box plots (n = 5) (b).
Engraftment of various HSC compartments in irradiated NSG mice is indicated (c). Rectangular regions define CD34++CD133+ and CD34++CD133−
precursors in the cBM (top row) and eBM (bottom row). The ratio of gated CD133+ to CD133− cells are indicated for cBM and eBM. The
expression HLA-DR, CD13 and CD33 on CD34++CD133+ and CD34++CD133− precursors from cBM and eBM is shown in histogram plots (d).
Staining with the indicated antibody is shown with blue shading, whereas staining with an isotype-matched control antibody is shown in
black outline
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has been used as a source of donor tissue for transplant-
ation and banks of fetal tissue have been established to
accommodate such efforts [40–42]. Many of these ef-
forts have centered around the use of fetal donor cells
for prenatal transplantation where the patient is also a
fetus, thereby matching the developmental stage of the
donor cells and the host. Although the fetal liver has
been most studied and used as a source of HSCs for
transplantation, fetal BM has also been evaluated as a
source of HSCs for transplantation [12]. The yield of
cells available from the long bones varies significantly
with gestational age and only by mid-gestation do these
tissues offer an abundant source of hematopoietic cells.
At 20 weeks’ gestation, we recovered 1.9 × 106 CD34++
CD133+ and 2.5 × 105 CD34++CD38low cells from the
harvest of all long bones, with 10-20 % of the cells
coming from the eBM preparation. These values are
comparable to the yields of cells from umbilical cord
blood [43, 44]. HSC recoveries from fetal BM obtained
at 23–24 weeks’ gestation can exceed those of a typical
umbilical cord blood harvest as demonstrated in this
study and previously by Golfier et al. [12]. The increased
yield of HSCs offered by harvesting eBM as well as the
greater proliferative and engraftment potential of eBM
HSCs clearly favors the harvest of eBM for any clinical
application.
Humanized mice were created by two methods to test
the engraftment of the eBM compartment in mice by
human HSCs. In the first model, intra-splenic injectionTable 2 Summary of hind limb BM content estimates by 59Fe distrib
Study Single femur Single tibia
Chervenick et al. 5.9 % 3.5 %
Schofield & Cole 7.0 % N.D.
Briganti et al. 6.1 % N.D.
Papayannopoulou & Finch 7.4 % N.D.
Lee et al. 6.1 % N.D.
Boggs et al. 6.7 % N.D.
Boggs & Patrene N.D. N.D.
Average: 6.5 % 3.5 %
aN.D. = Not Determined
bTwo different methods of preparation were performed yielding modestly differentwas used in mice that had not been preconditioned with
irradiation to preserve the integrity of the normal BM
environment. These mice were also transplanted with
fetal liver cells, a source of HSCs not compartmentalized
into cBM and eBM cells. We observed engraftment of
both BM compartments with human donor cells, show-
ing for the first time that human fetal liver cells do en-
graft the eBM. Similar findings were obtained when
mice were transplanted with cBM cells from fetal BM,
demonstrating that cBM can engraft the eBM niche.
These findings are in agreement with Guezguez et al.,
who observed that when human cells, engrafted in mice,
were isolated from either niche, they could reconstitute
both niches in secondary recipients [18]. We have also
successfully engrafted human multilineage hematopoiesis
in secondary murine hosts using cBM cells isolated by
the single-cut method [23]. Despite the capacity of HSCs
from cBM to engraft eBM, molecular and functional
differences between cBM and eBM have been observed
and are believed to be regulated, at least in part, by the
differences in the cBM and eBM niches [18].
The phenotypic analysis of fetal human hematopoietic
cells engrafted in mice also offered the opportunity to
evaluate the expression of several antigens expressed on
HSCs only early in ontogeny. We were interested to
determine if the fetal HSC phenotype changes to an
adult phenotype when cells are transplanted into an
adult mouse and analyzed at an age corresponding to
about 8 months after a normal term delivery. CD13 and
CD33 are generally described as myeloid differentiationution experiments
Single tibia + fibula Single hind leg Reference
N.D.a N.D. [34]
N.D. N.D. [35]
3.35 % N.D. [36]
N.D. N.D. [37]
3.05 % N.D. [38]
2.85 % N.D. [5]
N.D. 8.4 % & 10.75 %b [39]
3.1 % 9.6 %
results
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but these antigens are observed on fetal HSCs [26, 27].
Moreover, CD33 expression on fetal peripheral blood
HSCs (CD34+CD38− and CD34+CD117+) has been
shown to decline with gestational age, with its expres-
sion near absent at term birth [52]. Herein, we show
that CD13 expression is lost from fetal HSCs main-
tained in NSG mice, and that CD33 expression also
has declined but low level expression remains. The ex-
pression of these markers was similar for cBM and
eBM. These data show at least a partial shift towards
the adult HSC phenotype. HLA-DR expression remained
high on engrafted CD133+ HSCs, however, resembling the
expression observed in midgestation fetal liver [26, 27].
There was also a shift towards more HLA-DR expression
among early progenitors (CD34++CD133−) in the eBM
than in the cBM. These findings are in contrast to adult
cells for which evidence indicates that the most primi-
tive hematopoietic precursors lack HLA-DR expression
[29, 53–55]. Thus, based on HLA-DR expression, trans-
planted fetal HSCs do not appear to fully acquire an adult
phenotype after long-term reconstitution in immunodefi-
cient mice. It should be noted, however, that unavailability
of data on the HSC phenotype in children leaves open the
possibility that the human HSC phenotype observed in
our engrafted mice is actually representative of a hypo-
thetical transitional phenotype that may be observed in
neonates and young children.
Conclusions
For most experiments requiring mouse BM cells, the
single-cut method offers the simplest, most efficient and
fastest method of BM isolation from the femur and tibia.
The isolation of HSCs, however, is more complete using
enzymatic digestion to harvest the eBM. Enzymatic di-
gestion of human BM also increases the yield of cells
and HSCs, but the effects of the digestion on cell-
surface antigen expression must be tested to avoid false-
negative results. Humanized mice offer an in vivo model
to study trafficking of human HSC to the cBM and eBM
niches with changes in phenotype noted as fetal HSCs
aged in mice.
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